Now showing items 1-1 of 1

    • HIV/AIDS patients display lower relative bioavailability of Efavirenz than healthy subjects 

      Mukonzo, Jackson K; Nanzigu, Sara; Rekic, Dinko; Waako, Paul; Roshammar, Daniel; Ashton, Michael; Ogwal-Okeng, Jasper; Gustafsson, Lars L.; Aklillu, Eleni (Adis Data Information BV., 2011)
      Background: Pharmacokinetic studies of antiretroviral drugs are often conducted in adult healthy subjects, and the results are extrapolated to HIV/AIDS patients. HIV/AIDS, however, is known to cause morphological and ...